Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Post by francoisl13on May 17, 2024 1:25pm
117 Views
Post# 36045855

Technically speaking (update)

Technically speaking (update)As mentioned before, technical analysis for a microcap company is not as good as for larger companies but, it is interesting to note the following about KNE;
1. Short Term: The daily graph is in positive territory with a RSI above 60. The EMA10 is above the EMA30 which is also positive.
2. Mid-Term: The weekly graph is in positive territory with a RSI above 65. The EMA10 is above the EMA30 which is also positive.
3. Long-Term: The monthly graph moved into positive territory last month, RSI sits at 64. The EMA10 is about to cross the EMA30, when done, this will be another positive sign.
The only part missing is higher volume especially on a daily and weekly basis. Last month volume was huge so, the long-term signal is confirmed.
Exciting days ahead for KNE shareholders, that's for sure...
GLTA
<< Previous
Bullboard Posts
Next >>